LUGANO, Switzerland, Dec.

LUGANO, Switzerland, Aug.

LUGANO, Switzerland and SANDPOINT, Idaho, May 11, 2011 /PRNewswire/ -- Helsinn Group a rapidly growing pharmaceutical group based in Lugano, Switzerland, announced today the completion of a minority investment in Thorne Research, Inc., a leader in developing and manufacturing pure, high quality nutritional supplements marketed through licensed healthcare practitioners.

LUGANO, Switzerland, September 9 /PRNewswire/ -- As part of the Helsinn Group's development strategy, William Mann, PhD, has been appointed as new CEO in the American subsidiary, Helsinn Therapeutics (U.S.) Inc.

LUGANO, Switzerland, January 28 /PRNewswire/ -- Today the Swiss pharmaceutical group Helsinn announced the acquisition, of the US biopharmaceutical company, Sapphire Therapeutics Inc.